Back to Journals » OncoTargets and Therapy » Volume 8

The human immunodeficiency virus protease inhibitor ritonavir is potentially active against urological malignancies

Total article views   Abstract views HTML views PDF downloads Totals
7,587 Dovepress* 4,624 2,500+ 1,348 7,124
PubMed Central* 0 463 128 463
Totals 4,624 2,963 1,476 7,587
*Since 8 April 2015
+Since July 2016

View citations on PubMed Central and Google Scholar